EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials

Daniel A Gomes iD, João Presume, Pedro de Araújo Gonçalves, Manuel Sousa Almeida, Miguel Mendes, Jorge Ferreira

Cardiovascular Drugs and Therapy · 2025-04 · 39 (2) · 337-345

DOI: 10.1007/s10557-024-07547-3 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 12.01.2024. Verfasst von Daniel A Gomes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Av. Prof. Dr. Reinaldo Dos Santos, Carnaxide, 2790-134, Lisbon,…. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Weight Loss, Diabetes Mellitus, Type 2, Hypoglycemic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsWeight LossDiabetes Mellitus, Type 2Hypoglycemic AgentsGlycemic ControlBlood GlucoseAtherosclerosisIncretinsHumansRandomized Controlled Trials as TopicGlycated HemoglobinTreatment OutcomeRisk AssessmentMiddle AgedBlood PressureBiomarkersMaleCholesterol, LDL

Stichwörter der Autor:innen

Glucagon-like Peptide-1 Receptor AgonistsGlycemic ControlMajor Adverse Cardiovascular EventsType 2 DiabetesWeight Reduction

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanIncretinsBiomarkersCholesterol, LDL

Autor:innen und Institutionen

  • Cardiology Department, Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Av. Prof. Dr. Reinaldo Dos Santos, Carnaxide, 2790-134, Lisbon, Portugal. danielssagomes@gmail.com.
  • Cardiology Department, Hospital de Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Av. Prof. Dr. Reinaldo Dos Santos, Carnaxide, 2790-134, Lisbon, Portugal.
  • Comprehensive Health Research Centre, NOVA Medical School, Universidade Nova de Lisboa, Lisbon, Portugal.

ORCID-Profile: Daniel A Gomes

Zitieren

APA

Gomes, D. A., Presume, J., de Araújo Gonçalves, P., Almeida, M. S., Mendes, M., & Ferreira, J. (2025). Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials. Cardiovascular Drugs and Therapy, 39(2), 337-345. https://doi.org/10.1007/s10557-024-07547-3

Vancouver

Gomes DA, Presume J, de Araújo Gonçalves P, Almeida MS, Mendes M, Ferreira J. Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials. Cardiovascular Drugs and Therapy. 2025;39(2):337-345. doi:10.1007/s10557-024-07547-3

BibTeX
@article{Gomes2025,
  author = {Gomes, Daniel A and Presume, João and de Araújo Gonçalves, Pedro and Almeida, Manuel Sousa and Mendes, Miguel and Ferreira, Jorge},
  title = {Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2025},
  volume = {39},
  number = {2},
  pages = {337--345},
  doi = {10.1007/s10557-024-07547-3}
}
Kostenlos starten →